Literature DB >> 8833898

A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

E Meffre1, F LeDeist, G de Saint-Basile, A Deville, M Fougereau, A Fischer, C Schiff.   

Abstract

We report a detailed analysis of a B cell defect affecting a patient girl born from first cousin parents, characterized by a severe non-X-linked agammaglobulinemia with a total absence of CD19- cells in the periphery. In the bone marrow, CD19 expression was also highly impaired, resulting in the absence of both B and preB compartments. By contrast, CD34+CD10+, CD34psiL+, and some CD19+CD10+ mostly CD34+ early proB cells were present, although diminished. Semiquantitative RT-PCR analysis performed on mononuclear bone marrow cells indicated that lambda-like, VpreB, Rag-1, Rag-2, and TdT transcripts expressed during proB cell stages were found at normal levels whereas E2A, CD10, Syk, Pax-5, CD19, Igalpha, Igbeta, VH-Cmu, and Vkappa-Ckappa transcripts characteristic of later stages were severely depressed. This phenotype resembles that of Pax-5 knock-out mice, but since the coding sequence of the patient Pax-5 cDNA was shown to be normal, the defect might rather result from an altered regulation of this gene. All these data indicate that the patient suffers from a new genetic defect that results in an arrest of differentiation within the proB cell compartment, i.e., earlier than X-linked agammaglobulinemia, before the onset of Ig gene rearrangements.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833898      PMCID: PMC507582          DOI: 10.1172/JCI118943

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

Review 1.  Regulation of genome rearrangement events during lymphocyte differentiation.

Authors:  F W Alt; T K Blackwell; R A DePinho; M G Reth; G D Yancopoulos
Journal:  Immunol Rev       Date:  1986-02       Impact factor: 12.988

2.  Immunobiologic differences between normal and leukemic human B-cell precursors.

Authors:  F M Uckun; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  B cells in patients with X-linked agammaglobulinemia.

Authors:  M E Conley
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

4.  B29: a member of the immunoglobulin gene superfamily exclusively expressed on beta-lineage cells.

Authors:  G G Hermanson; D Eisenberg; P W Kincade; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes.

Authors:  N Sakaguchi; F Melchers
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

6.  Immunoglobulin lambda light-chain-related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin omega light-chain protein.

Authors:  G F Hollis; R J Evans; J M Stafford-Hollis; S J Korsmeyer; J P McKearn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

7.  Establishment of a leukemic cell model for studying human pre-B to B cell differentiation.

Authors:  B Wörmann; J M Anderson; J A Liberty; K Gajl-Peczalska; R D Brunning; T L Silberman; D C Arthur; T W LeBien
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes.

Authors:  A Kudo; N Sakaguchi; F Melchers
Journal:  EMBO J       Date:  1987-01       Impact factor: 11.598

9.  B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties.

Authors:  N Sakaguchi; S Kashiwamura; M Kimoto; P Thalmann; F Melchers
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

10.  Structure and pre-B lymphocyte restricted expression of the VpreB in humans and conservation of its structure in other mammalian species.

Authors:  S R Bauer; A Kudo; F Melchers
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  7 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 3.  New frontiers of primary antibody deficiencies.

Authors:  Mirjam van der Burg; Menno C van Zelm; Gertjan J A Driessen; Jacques J M van Dongen
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

4.  Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development.

Authors:  E Meffre; M Milili; C Blanco-Betancourt; H Antunes; M C Nussenzweig; C Schiff
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  Mutations in Igalpha (CD79a) result in a complete block in B-cell development.

Authors:  Y Minegishi; E Coustan-Smith; L Rapalus; F Ersoy; D Campana; M E Conley
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans.

Authors:  Akihisa Sawada; Yoshihiro Takihara; Ji Yoo Kim; Yoshiko Matsuda-Hashii; Sadao Tokimasa; Hiroyuki Fujisaki; Keiko Kubota; Hiroko Endo; Takashi Onodera; Hideaki Ohta; Keiichi Ozono; Junichi Hara
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 7.  Update on Infections in Primary Antibody Deficiencies.

Authors:  Yesim Yilmaz Demirdag; Sudhir Gupta
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.